Information Provided By:
Fly News Breaks for September 29, 2015
RMTI
Sep 29, 2015 | 08:39 EDT
After Rockwell's stock tumbled 25% this year, Oppenheimer says that the company's fundamentals remain intact. The firm thinks that the stock has several potential positive catalysts, including a fast ramp of its Triferic drug, a fast path to profitability and potential business development activities. It keeps a $26 price target and Outperform rating.
News For RMTI From the Last 2 Days
There are no results for your query RMTI